Bright Minds Biosciences (DRUG) Beginning Cash Balance (2020 - 2026)
Bright Minds Biosciences' (DRUG) quarterly Beginning Cash Balance came in at $59.5 million in Q4 2025, up 1351.93% YoY from $4.1 million in Q4 2024, and up 1351.93% on a QoQ basis from $4.1 million in Q4 2024.
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Beginning Cash Balance (2020 - 2026) Analysis & Trends
Bright Minds Biosciences (DRUG) has 6 years of Beginning Cash Balance data on file, last reported at $59.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Bright Minds Biosciences | 449.62 Mn | 227.08 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.94 Mn |
| Mar 31, 2026 | 60.46 Mn |
| Dec 31, 2025 | 59.45 Mn |
| Sep 30, 2025 | 4.16 Mn |
| Jun 30, 2025 | 4.13 Mn |
| Mar 31, 2025 | 3.99 Mn |
| Dec 31, 2024 | 4.09 Mn |
| Sep 30, 2024 | 4.95 Mn |
| Jun 30, 2024 | 4.93 Mn |
| Mar 31, 2024 | 5.01 Mn |
| Dec 31, 2023 | 4.96 Mn |
| Sep 30, 2023 | 8.67 Mn |
| Jun 30, 2023 | 8.66 Mn |
| Mar 31, 2023 | 8.60 Mn |
| Dec 31, 2022 | 8.57 Mn |
| Sep 30, 2022 | 15.15 Mn |
| Jun 30, 2022 | 15.50 Mn |
| Mar 31, 2022 | 15.60 Mn |
| Dec 31, 2021 | 15.68 Mn |
| Sep 30, 2021 | 635,471.04 |